Mary Fidler to Aniline Compounds
This is a "connection" page, showing publications Mary Fidler has written about Aniline Compounds.
Connection Strength
0.053
-
Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial. J Thorac Oncol. 2023 09; 18(9):1209-1221.
Score: 0.053